Infectious Disease Therapeutics Market Size to Exceed $196.5 Billion by 2029 | Growth and Industry Trends
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Fast Is The Infectious Disease Therapeutics Market Expected to Grow Between 2025 And 2029?
The market size of therapeutics for infectious diseases has experienced significant growth in the past few years. The market, which will increase from $141.08 billion in 2024 to $151.04 billion in 2025, is projected to have a compound annual growth rate (CAGR) of 7.1%. The expansion during the historical period can be credited to various factors such as increased occurrence of infectious diseases, a rise in viral disease cases, heightened awareness regarding diagnosis, escalating demand for rapid and effective diagnostic tests, increased demand for affordable generic drugs, a growing incidence of infectious diseases, and an elevated significance of antimicrobial stewardship.
What Growth Rate Is Anticipated for the Infectious Disease Therapeutics Market in the Coming Years?
The market for therapeutic treatments related to infectious diseases is projected to see a robust surge in the coming years, escalating to reach $196.5 billion by 2029 with a CAGR of 6.8%. This looming growth in the forecasted timeline can be credited to a rise in investments, a broader scope of clinical trial studies, an upturn in the number of clinical trials, a heightened emphasis on preventing infectious diseases, growing consciousness about early diagnosis and an increase in awareness and funding. The key trends anticipated during the forecasted period entail partnerships, product endorsements, advancements in investment and research in therapeutics.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15594&type=smp
Who Are the Leading Companies in the Infectious Disease Therapeutics Market?
Major companies operating in the infectious disease therapeutics market are Pfizer Inc., Roche Diagnostics Corporation, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi SA, Thermo Fisher Scientific, AstraZeneca, Abbott Laboratories, Novartis International AG, Danaher Corporation, GlaxoSmithKline plc, Gilead Sciences Inc., Janssen Pharmaceutical, Siemens Healthineers, Moderna Inc., Becton, Dickinson, and Company, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim GmbH, BioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories, Qiagen N.V., Ortho Clinical Diagnostics, BioCryst Pharmaceuticals Inc.
What Are the Key Drivers of the Infectious Disease Therapeutics Market?
Expectations for the infectious disease therapeutics market’s expansion are being fueled by the increasing prevalence of infectious diseases. Such diseases, brought on by pathogens like bacteria, viruses, fungi, parasites, or prions, are on the rise due to numerous key elements including climate shifts, environmental upheaval, antimicrobial resistance, compromised immune systems, more interactions with animals, and ecological imbalances. Therapies for infectious diseases are critical in managing infections, reducing cases and deaths, and limiting the transmission of easily spread diseases within and between populations. As an example, the US-based Centers for Disease Control and Prevention reported in November 2023 that the United States saw 8,331 tuberculosis (TB) cases in 2022, which corresponds to an incidence rate of 2.5 per 100,000 people. This represents a 5.9% rise in cases and a 5.5% jump in the incidence rate compared to 2021. Consequently, this increasing prevalence of infectious diseases is fueling the growth of the infectious disease therapeutics market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=15594&type=smp
What Are the Key Market Segments in the Infectious Disease Therapeutics Industry?
The infectious disease therapeutics market covered in this report is segmented –
1) By Type: Drugs, Vaccines
2) By Disease: Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases
3) By End-User: Hospitals And Clinics, Retail Pharmacies, Research Organizations, Other End Users
Subsegments:
1) By Drugs – Antibiotics, Antivirals, Antifungals, Antiparasitics, Other Therapeutic Drugs (Monoclonal Antibodies, Immunomodulators)
2) By Vaccines – Inactivated Vaccines, Live Attenuated Vaccines, Subunit Vaccines, Mrna Vaccines, Dna Vaccines, Toxoid Vaccines
What Are the Latest Trends in the Infectious Disease Therapeutics Market?
Leading corporations in the infectious disease therapeutics market are channeling resources into the development of drugs for infectious diseases. Their goals are to produce more effective treatments, fight antimicrobial resistance, broaden their range of products, and tackle new threats from infectious diseases. These investment strategies are designed to enhance patient outcomes, fulfill unfulfilled healthcare prerequisites, and lend support to global public health drives targeted at controlling and treating infectious diseases. Take for example, GSK, a healthcare firm from the UK, which in June 2022, allocated £1 billion ($1.09 billion) to proactively tackle infectious diseases in less affluent nations. The objective of this plan is to accelerate research and development activities to fight diseases that disproportionately affect these areas. The unequal distribution of funding and resources for health research between affluent and low- to middle-income countries emphasizes the pressing need for such anticipatory investments to fairly enhance population health.
Access The Full Report Here:
What Are the Key Regional Markets in the Infectious Disease Therapeutics Industry?
North America was the largest region in the infectious disease therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15594
This Report Delivers Insight On:
1. How big is the infectious disease therapeutics market, and how is it changing globally?
2. Who are the major companies in the infectious disease therapeutics market, and how are they performing?
3. What are the key opportunities and risks in the infectious disease therapeutics market right now?
4. Which products or customer segments are growing the most in the infectious disease therapeutics market?
5. What factors are helping or slowing down the growth of the infectious disease therapeutics market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
